LASSO expression score distinguishes delayed kidney-graft function in retrospective cohorts
Source check: Source checked. Not independent scientific confirmation.
Finding: A three-gene LASSO score was evaluated against observed delayed graft function after kidney transplantation. The study reports AUC 0.730 in an internal test split and 0.773 in a small separate biopsy cohort. This is retrospective clinical discrimination, without demonstrated prevention, treatment benefit or prospective deployment.
Technology: Ten-fold cross-validated LASSO for a three-gene delayed-graft-function score
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- LASSO learned nonzero expression features and coefficients for a combined score evaluated against measured clinical graft-function outcomes. Generic pathway enrichment and recovery of known inflammatory biology are not the represented finding.
- Test and result
- From 202 post-reperfusion samples with graft-function information, the source made a 70:30 training/internal-test split. Training-set LASSO selected ANXA1, HSP90AA1 and NFKBIA. Reported AUC was 0.730 internally and 0.773 in GSE90861, a separate cohort of 23 paired-biopsy recipients, twelve with delayed and eleven with immediate graft function.
- Limitation / still unknown
- Small retrospective datasets and donor-type differences limit generalization. The separate cohort also informed earlier expression confirmation of candidate genes, so it is not a wholly untouched evaluation of the entire discovery workflow. Individual-patient split independence and supplementary implementation were not reconstructed. No causal necroptosis mechanism, reduced rejection, therapeutic benefit or locked prospective prediction was established by the represented model evaluation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10141843/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Read actual primary PMC cohort acquisition, gene-screening, LASSO training/internal split and external-evaluation Methods plus DGF Results through the web primary-text route. Publisher canonical front and fresh PubMed notice metadata checked. Graft-survival supplementary model and individual-patient reconstruction were not independently adjudicated. Exact original article front DOI/title and fresh PubMed primary relationship metadata checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.